Part of the rational for this line of research has been that HR- breast cancers are also more commonly diagnosed among carriers of mutations in the BRCA1 gene, providing some evidence for germline genetic risk factors in the development of specific breast cancer subtypes [20]. The gene discussed is BRCA1; the disease is breast cancer.